Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386968779> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4386968779 endingPage "S9" @default.
- W4386968779 startingPage "S7" @default.
- W4386968779 abstract "Atrial fibrillation (AF) is a potentially serious health risk, both because of its symptoms and because of its association with an increased risk for heart failure, hospitalization, thromboembolism, and death. Chapter 2 discusses selection of appropriate treatments and when to initiate these therapies. Older trials focused on comparing rate versus rhythm control treatment options for AF. It is now recognized that both rate and rhythm control are important and can be used together. This chapter reviews the historical, pivotal rate versus rhythm control trials that failed to show any overall survival benefit of rhythm over rate control, as well as the trials' now-recognized limitations with respect to modern therapy. In addition, an in-depth discussion of the more recent trials of antiarrhythmic drugs (AAD) and ablation techniques (which have become available since the original rate versus rhythm trials were performed) is included. These updated trials show that when applied to patient- and disease-specific situations, rhythm control can reduce the risk for mortality and hospitalization. The chapter also reviews the guidelines that have been developed to achieve these goals. Chapter 2 is summarized as follows: (1) Rate control is needed (at rest and during exertion) to reduce rate-related symptoms when rhythm control is ineffective or incomplete and to prevent a tachycardia-induced cardiomyopathy. (2) Previous trials with pharmacological therapy alone comparing rate versus rhythm control using the AADs available at that time failed to show any overall survival benefit of rhythm control over rate control. (3) These earlier trials had many methodological limitations and enrolled participants who did not have access to modern therapies. (4) Newer therapies, including those for stroke prevention, dronedarone (the latest approved AAD), and AF ablation, have improved the safety and efficacy of rhythm control strategies." @default.
- W4386968779 created "2023-09-23" @default.
- W4386968779 creator A5035437346 @default.
- W4386968779 creator A5055404194 @default.
- W4386968779 creator A5058588504 @default.
- W4386968779 creator A5062028137 @default.
- W4386968779 date "2023-10-01" @default.
- W4386968779 modified "2023-10-12" @default.
- W4386968779 title "Chapter 2: Rate Versus Rhythm Control" @default.
- W4386968779 doi "https://doi.org/10.1016/j.amjcard.2023.08.022" @default.
- W4386968779 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37777298" @default.
- W4386968779 hasPublicationYear "2023" @default.
- W4386968779 type Work @default.
- W4386968779 citedByCount "0" @default.
- W4386968779 crossrefType "journal-article" @default.
- W4386968779 hasAuthorship W4386968779A5035437346 @default.
- W4386968779 hasAuthorship W4386968779A5055404194 @default.
- W4386968779 hasAuthorship W4386968779A5058588504 @default.
- W4386968779 hasAuthorship W4386968779A5062028137 @default.
- W4386968779 hasConcept C126322002 @default.
- W4386968779 hasConcept C135343436 @default.
- W4386968779 hasConcept C164705383 @default.
- W4386968779 hasConcept C168563851 @default.
- W4386968779 hasConcept C177713679 @default.
- W4386968779 hasConcept C2777953023 @default.
- W4386968779 hasConcept C2779161974 @default.
- W4386968779 hasConcept C2780283014 @default.
- W4386968779 hasConcept C535046627 @default.
- W4386968779 hasConcept C71924100 @default.
- W4386968779 hasConcept C84393581 @default.
- W4386968779 hasConceptScore W4386968779C126322002 @default.
- W4386968779 hasConceptScore W4386968779C135343436 @default.
- W4386968779 hasConceptScore W4386968779C164705383 @default.
- W4386968779 hasConceptScore W4386968779C168563851 @default.
- W4386968779 hasConceptScore W4386968779C177713679 @default.
- W4386968779 hasConceptScore W4386968779C2777953023 @default.
- W4386968779 hasConceptScore W4386968779C2779161974 @default.
- W4386968779 hasConceptScore W4386968779C2780283014 @default.
- W4386968779 hasConceptScore W4386968779C535046627 @default.
- W4386968779 hasConceptScore W4386968779C71924100 @default.
- W4386968779 hasConceptScore W4386968779C84393581 @default.
- W4386968779 hasFunder F4320307781 @default.
- W4386968779 hasLocation W43869687791 @default.
- W4386968779 hasLocation W43869687792 @default.
- W4386968779 hasOpenAccess W4386968779 @default.
- W4386968779 hasPrimaryLocation W43869687791 @default.
- W4386968779 hasRelatedWork W156686077 @default.
- W4386968779 hasRelatedWork W2064134577 @default.
- W4386968779 hasRelatedWork W2072492413 @default.
- W4386968779 hasRelatedWork W2080208020 @default.
- W4386968779 hasRelatedWork W2087220383 @default.
- W4386968779 hasRelatedWork W2142453885 @default.
- W4386968779 hasRelatedWork W2373995729 @default.
- W4386968779 hasRelatedWork W2426044314 @default.
- W4386968779 hasRelatedWork W2997159972 @default.
- W4386968779 hasRelatedWork W4296378967 @default.
- W4386968779 hasVolume "205" @default.
- W4386968779 isParatext "false" @default.
- W4386968779 isRetracted "false" @default.
- W4386968779 workType "article" @default.